Wakol Sealing Compounds

for General Line - Round

Способ нанесения

• Suitable for common lining systems

• Suitable for all common feeding systems

Filling/Packaging

  • Suitable for demanding technical filling goods

Advantages

• Good to excellent chemical resistance

• Suitable for commonly used filling goods

Additional Information

• Food contact approved
Pre-vulcanised products

Pre-vulcanised products

Special Advantages

  • Insensitive to process conditions

  • Longer shelf life

Special Advantages

  • Suitable for medium-speed liners

  • Very good resistance against water, fats, oils, and organic solvents

  • Also for food products without further thermal treatment

  • Hot filling possible

Properties Range

  • Solid content: 67,5%

  • Viscosity (WPV 74): 200 mPas

  • Density dry: 1,62 g/cm³

  • Density wet: 1,35 g/cm³

Additional Information

  • Certificate available

  • Regulation (EC) 1935/2004/EG

  • FDA 21 CFR 175.300


Special Advantages

  • Suitable for slow-to mediumspeed liners

  • Good adhesion on all common lacquers

  • Good shear stability

  • Long-term market experience

  • Very good chemical resistance

  • Suitable for pasteurization

Properties Range

  • Solid content: 40-67%

  • Viscosity (WPV 74): 100-330 mPas

  • Density dry: 1,53-1,60 g/cm³

  • Density wet: 1,29-1,33 g/cm³

  • Colour: grey, red, dark red

Additional Information

  • Certificate available

  • Regulation (EC) 1935/2004/EG

  • FDA 21 CFR 175.300


Vulcanising products

Vulcanising products

Special Advantages

  • Excellent chemical resistance

  • Higher modulus

Special Advantages

  • Suitable for medium- to high-speed liners

  • Good adhesion on all common lacquers

  • Low sedimentation tendency

  • Highly cost-efficient

  • Improved shear stability

Properties Range

  • Solid content: 67-69%

  • Viscosity (WPV 74): 230-410 mPas

  • Density dry: 1,28 g/cm³

  • Density wet: 1,18 g/cm³

  • Colour: red, grey

Additional Information

  • Certificate available

  • Regulation (EC) 1935/2004/EG

  • FDA 21 CFR 175.300